Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options

W Löscher, H Potschka, SM Sisodiya, A Vezzani - Pharmacological reviews, 2020 - ASPET
Epilepsy is a chronic neurologic disorder that affects over 70 million people worldwide.
Despite the availability of over 20 antiseizure drugs (ASDs) for symptomatic treatment of …

The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond

W Löscher, P Klein - CNS drugs, 2021 - Springer
Epilepsy is one of the most common and disabling chronic neurological disorders.
Antiseizure medications (ASMs), previously referred to as anticonvulsant or antiepileptic …

Infections, inflammation and epilepsy

A Vezzani, RS Fujinami, HS White, PM Preux… - Acta …, 2016 - Springer
Epilepsy is the tendency to have unprovoked epileptic seizures. Anything causing structural
or functional derangement of brain physiology may lead to seizures, and different conditions …

Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs

W Löscher - Neurochemical research, 2017 - Springer
The identification of potential therapeutic agents for the treatment of epilepsy requires the
use of seizure models. Except for some early treatments, including bromides and …

Neuroinflammation and proinflammatory cytokines in epileptogenesis

A Soltani Khaboushan, N Yazdanpanah… - Molecular neurobiology, 2022 - Springer
Increasing evidence corroborates the fundamental role of neuroinflammation in the
development of epilepsy. Proinflammatory cytokines (PICs) are crucial contributors to the …

Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

P Klein, R Dingledine, E Aronica, C Bernard… - …, 2018 - Wiley Online Library
The most common forms of acquired epilepsies arise following acute brain insults such as
traumatic brain injury, stroke, or central nervous system infections. Treatment is effective for …

[HTML][HTML] Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective

A Talevi - Frontiers in pharmacology, 2015 - frontiersin.org
Multi-target drugs have raised considerable interest in the last decade owing to their
advantages in the treatment of complex diseases and health conditions linked to drug …

Structural, molecular, and functional alterations of the blood-brain barrier during epileptogenesis and epilepsy: a cause, consequence, or both?

W Löscher, A Friedman - International journal of molecular sciences, 2020 - mdpi.com
The blood-brain barrier (BBB) is a dynamic, highly selective barrier primarily formed by
endothelial cells connected by tight junctions that separate the circulating blood from the …

Indication of dynamic peroxynitrite fluctuations in the rat epilepsy model with a near-infrared two-photon fluorescent probe

X Luo, Z Cheng, R Wang, F Yu - Analytical Chemistry, 2021 - ACS Publications
Epilepsy is a chronic neurodegenerative disease that has seriously threatened human
health. Accumulating evidence reveals that the pathological progression of epilepsy is …

Epilepsy, antiepileptic drugs, and aggression: an evidence-based review

MJ Brodie, F Besag, AB Ettinger, M Mula, G Gobbi… - Pharmacological …, 2016 - ASPET
Antiepileptic drugs (AEDs) have many benefits but also many side effects, including
aggression, agitation, and irritability, in some patients with epilepsy. This article offers a …